E&C Committee holds hearing on Medicare and Medicaid fraud

April 15, 2026

medicaid Medicare

On March 17, the House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing titled, “Protecting Patients and Safeguarding Taxpayer Dollars: The Role of CMS in Combatting Medicare and Medicaid Fraud.” During the hearing, members agreed that fraud in federal health care programs is a serious problem but diverged on whether current oversight efforts are politically motivated.

The Centers for Medicare & Medicaid Services (CMS) testified about agency efforts to curb fraud, including shifting away from a “pay-and-chase” model towards front-end fraud prevention using new machine learning algorithms to flag suspicious claims. CMS also highlighted its Comprehensive Regulation for Uncovering Suspicious Healthcare (CRUSH) Request for Information (RFI) to inform future rulemaking.

The Cigna Group submitted RFI comments on March 30 supporting increased collaboration with CMS and strengthening coordination between programs to stop fraudulent actors from shifting between programs. We recommend that CMS pilot efforts first with high-risk sectors and geographic hotspots. We also raise concerns about fraudulent provider upcoding, fraudulent activity in the No Surprises Act Independent Dispute Resolution process, and broker oversight in the federal Marketplace.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like